Elisabetta Fenocchio

9PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Margherita Rimini, Lorenzo Fornaro, Masafumi Ikeda

|Sep 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

|Jun 28, 2023
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.

Alessio Rizzo, Manuela Racca, Federico Garrou

|Mar 02, 2023
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.

Joris van de Haar, Xuhui Ma, Salo N Ooft

|Aug 01, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.

Andrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi

Pageof 2

Frequent Collaborators

3 joint publications

Sara Lonardi

2 joint publications

Edoardo Crimini

2 joint publications

Enrico Berrino

2 joint publications

Giovanni Blandino